Applied DNA Sciences (APDN) Reports In-Line Q4 EPS, Miss on Revenues
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Selling, general and administrative: 1.86M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Financial Fact:
Selling, general and administrative: 1.86M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q4 EPS of ($0.10), in-line with the analyst estimate of ($0.10). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $1.67 million.
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) Tops Q1 EPS by 19c, Beats on Revenue; Beats on Cloud Revenue, Offers Q3 EPS Guidance
- AeroVironment (AVAV) Tops Q1 EPS by 29c, Offers Guidance
- Macy's (M) Tops Q2 EPS by 28c, Beats on Revenue; Offers FY Guidance
Create E-mail Alert Related Categories
Corporate News, Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
